We explore the science, scalability, and (of course) economics surrounding the global vaccine race. Guests include the chief medical officer of the first U.S. firm to go to Phase 3 trials with a vaccine candidate; a former F.D.A. commissioner whoβs been warning of a pandemic for years; and an economist who thinks Covid-19 may finally change how diseases are cured.
π 2020-08-22 05:00 / β 00:42:53
π 2020-08-20 05:00 / β 00:54:43
π 2020-08-13 05:00 / β 00:41:08
π 2020-08-06 05:00 / β 00:43:49
π 2020-07-30 05:00 / β 00:32:15